Association of response to doxycycline and Azithromycin antibiotics therapy with Angiotensin converting enzyme polymorphism in patients with moderate acne vulgaris

Phase 2

Recruiting

• Conditions: Acne vulgaris.; L70.0; Acne vulgaris

• Registration Number: IRCT20230305057628N1
• Lead Sponsor: Gonabad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Acne vulgaris with moderate severity according to the MAS SCORE classification system
Suffering from acne vulgaris with moderate severity according to Weishampain's classification system

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Angiotensin converting enzyme gene polymorphism. Timepoint: After the end of the treatment period. Method of measurement: PCR and electrophoresis.;Response to treatment. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: MAS score.